China's Betta Pharma Hits Limit-Down After Duravyu Fails to Match Rival Eye DrugYicai·Aug 18 at 10:59 AMEYPT+0.33%300558-0.35%
22:16 ETGroundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicineprnewswire·Jul 9 at 02:18 AM300558-0.35%
